SavedAdd your journal

Journals / Çukurova Tıp Öğrenci Dergisi / 2022 / Cilt: 2 - Sayı: 2

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

Serebral otozomal dominant arteriyopati ile subkortikal enfarktlar ve lökoensefalopati (CADASIL)

Gül ATEŞ
Melise Gözde KÜTÜK
Şebnem BIÇAKCI
Pages
59–65
Publication Date
2022-12-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we tried to compile and present the effects, symptoms and neuropathology of CADASIL disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a small vessel disease.
📊
Key Findings & Data:It is an autosomal dominant inherited disease caused by a mutation in the Notch3 gene.
💡
Conclusion & Impact:In this article, we tried to compile and present the effects, symptoms and neuropathology of CADASIL disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:CADASIL · Notch3 geni · mutasyon

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a small vessel disease. It is an autosomal dominant inherited disease caused by a mutation in the Notch3 gene. It affects many systems as it gives multiple symptoms. The earliest and most common symptom is migraine. It is thought that the Notch3 gene may act as a sensitivity marker in migraine with aura. It has been reported more frequently with ischemic stroke attack. It may also present with acute leukoencephalopathy, accompanied by seizures and cognitive changes. Psychiatric symptoms, defined as vascular depression and complicating the patient's social life, are observed. In addition, due to small vessel disease, we may encounter peripheral neuropathy and myopathy in some patients. Family screening and genetic counseling have an important place here, as it can show different phenotypes due to environmental effects and is an autosomal dominant disease. In this article, we tried to compile and present the effects, symptoms and neuropathology of CADASIL disease.

Özet

Serebral otozomal dominant arteriyopati ile subkortikal enfarklar ve lökoensefalopati (CADASIL) küçük damar hastalığıdır. Notch3 genindeki mutasyon sonucunda ortaya çıkan otozomal dominant geçişli bir hastalıktır. Birden fazla semptom verdiğinden bir sürü sistemi etkiler. En erken ve sık belirtisi migrendir. Auralı migrende Notch3 geninin duyarlılık belirteci olarak davranabileceği düşünülmektedir. Daha sık iskemik inme atağıyla raporlanmıştır. Nöbetler ve bilişsel değişikliklerle beraber seyreden akut lökoensefalopati tablosuyla da gelebilir. Vasküler depresyon olarak tanımlanan ve hastanın sosyal hayatını zorlaştıran psikiyatrik semptomlar görülmektedir. Bunun yanı sıra küçük damar hastalığı olduğundan bazı hastalarda periferik nöropati ve myopatiye de rastlayabiliriz. Çevre etkisiyle de değişik fenotip gösterebildiği ve otozomal dominant bir hastalık olması sebebiyle aile taraması ve genetik danışmanlık burada önemli bir yer tutmaktadır. Bu makalede CADASIL hastalığının etkileri, semptomları ve nöropatolojisi gözden geçirilmiştir.

🔖

Cite This Article

ATEŞ, G., KÜTÜK, M. G., BIÇAKCI, Ş. (2022). Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Çukurova Tıp Öğrenci Dergisi, Cilt: 2 - Sayı: 2, 59–65. https://ajindex.com/articles/873290

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.Nature. 1996;383:707-10
  2. Narayan SK, Gorman G, Kalaria RN, Ford GA, Chinnery PF. The minimum prevalence of cadasil in England. Neurology. 2012;78:1025-7
  3. Boussier Mg, Tournier- Lasserve E. Summary of the proceedings of the first International Workshop on CADASIL. Stroke. 1994;25:704-7
  4. Sabbadini G, Francia A, Calandriello L, Di Biasi C, Trasimeni G, Gualdi GF et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). Clinical, neuroimaging, pathological and genetic study of a large Italian family. Brain. 1995;118:207-15
  5. Mas JL, Dilouya A, de Recando J. A familial disorder with subcortical ischemic strokes, dementia and leukoencephalopathy. Neurology. 1992;42:1015-9
  6. Donnini I, Nannucci S, Valenti R, Pescini F, Bianchi S, Inzitari D et al. Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience. J Headache Pain. 2012;13:299-302
  7. Monteiro C, Barros J, Tipa R, Pereira-Monteiro J. Sporadic hemiplegic migraine as the initial manifestation of Cadasil. Cephalalgia. 2012;32:255-7
  8. Benisty S, Reyes S, Godin O, Herve D, Zieren N, Jouvent E et al. White matter lesions without lacuner infarcts in CADASIL. J Alzheimers Dis. 2012;29:903-11
  9. Dominquez-Sanchez FJ, Lasa-Aristu A, Gomi-Imızcoz M. Intelligence impairment, personality and psychopathology disturbances in a familiy affected with CADASIL. Span J Psychol. 2011;14:936-43
  10. Uchino M. The pathomechanism and treatment of CADASIL. Rinsho Shinkeigaku. 2011;51:945-8
  11. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P et al. Notch3 mutations in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a mendelian condition causing stroke and vascular dementia. Ann N Y Acad Sci. 1997;826:213-7
  12. Yuan P, Salvadore G, Li X, Zhang L, Du J, Chen G et al. Valproate activates the Notch3/c-FLIP signaling cascade: a strategy to attenuate white matter hyperintensities in bipolar disorder in late life? Bipolar Disord. 2009;11:256-69
  13. Eikermann-Haerter K, Yuzawa I, Dilekoz E, Joutel A, Moskowitz MA, Ayata C. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression. Ann Neurol. 2011;69:413–8